[1]
Purbandini, C.S. and Sauriasari, R. 2018. COST-EFFECTIVENESS ANALYSIS OF CEFTRIAXONE AND NON-CEFTRIAXONE ON TYPHOID FEVER PATIENTS. International Journal of Applied Pharmaceutics. 10, 1 (Dec. 2018), 87–91. DOI:https://doi.org/10.22159/ijap.2018.v10s1.18.